Fluorescence lifetime imaging of treatment response in neuroendocrine tumor organoids

Amani A. Gillette,Christopher P. Babiarz,Cheri A. Pasch,Dustin A. Deming,Melissa C. Skala

CANCER RESEARCH（2019）

引用 0|浏览5

暂无评分

摘要

NAD(P)H and FAD fluorescence lifetime imaging is used to monitor cancer metabolism. Imaging of 3D primary gastroenteropancreatic neuroendocrine organoids reveals patient specific metabolic differences in response to treatment.

查看译文

关键词

Neuroendocrine Tumors,Pancreatic Neuroendocrine Tumors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要